Red Tortoise LLC’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-102
Closed -$2.81K 618
2025
Q2
$2.81K Buy
+102
New +$2.69K ﹤0.01% 466
2023
Q4
Sell
-16
Closed -$1.65K 567
2023
Q3
$1.65K Buy
+16
New +$1.78K ﹤0.01% 478
2023
Q1
Sell
-20
Closed -$3.59K 591
2022
Q4
$3.59K Buy
+20
New +$3.27K ﹤0.01% 370

Other funds holding MRNA

Red Tortoise LLC's MRNA Position: Q3 2025 in Review

Red Tortoise LLC sold out of Moderna (MRNA) in Q3 2025, closing a stake of 102 shares — an estimated $2.81K sold.

Red Tortoise LLC first reported a position in MRNA in Q4 2022 and held it in 3 quarters. The position peaked at $3.59K in Q4 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Red Tortoise LLC reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Red Tortoise LLC sold 102 Moderna shares in Q3 2025, an estimated $2.81K.
  • Red Tortoise LLC first reported a position in Moderna in Q4 2022 and held it in 3 quarters.
  • Red Tortoise LLC's Moderna position peaked at $3.59K in Q4 2022.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Red Tortoise LLC's 13F filing for Q3 2025, filed 22 Oct 2025.